Company Quick10K Filing
GlaxoSmithKline
20-F 2019-12-31 Filed 2020-03-06
20-F 2018-12-31 Filed 2019-03-15
20-F 2017-12-31 Filed 2018-03-16
20-F 2016-12-31 Filed 2017-03-17
20-F 2015-12-31 Filed 2016-03-18
20-F 2013-12-31 Filed 2014-02-28
20-F 2012-12-31 Filed 2013-03-08
20-F 2011-12-31 Filed 2012-03-13
20-F 2010-12-31 Filed 2011-03-04
20-F 2009-12-31 Filed 2010-03-01

GlaxoSmithKline Financials

GSK Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Johnson & Johnson (JNJ) 345,690 66% 16.4 9% 155,521 97,311 81,706 54,323 14,151 21,578 354,665
Merck (MRK) 214,488 70% 18.9 9% 83,331 56,493 34,973 24,530 7,492 12,141 229,294
Pfizer (PFE) 207,742 81% 12.0 10% 170,446 105,051 39,062 31,451 16,629 20,353 243,371
GlaxoSmithKline (GSK) 200,316 0% 58,066 54,394 0 0 0 0 225,704
Novartis (NVS) 197,050 0% 145,563 66,871 0 0 0 0 193,929
Abbott (ABT) 150,169 59% 16.4 5% 67,887 36,586 31,904 18,673 3,687 10,019 164,168
AbbVie (ABBV) 109,786 77% 21.1 5% 59,441 67,667 32,867 25,412 3,255 6,259 132,264
Eli Lilly (LLY) 105,897 78% 12.7 21% 37,893 34,431 22,644 17,612 7,948 9,419 119,560
Beigene (BGNE) 100,124 74% -123.1 -44% 1,881 587 430 318 -827 -807 99,328
Bristol Myers Squibb (BMY) 82,160 70% 10.6 10% 57,433 39,679 24,173 16,837 5,680 7,151 76,061
Celgene (CELG) 72,111 96% 10.4 14% 41,363 29,276 16,982 16,354 5,880 7,734 80,796
Zoetis (ZTS) 60,799 51% 29.1 13% 11,272 8,594 6,150 3,124 1,461 2,252 65,484
Allergan (AGN) 54,957 63% -241.2 -5% 122,925 38,486 15,818 9,949 -5,872 -316 76,270
Sanofi (SNY) 52,845 0% 111,408 0 0 0 0 52,184
GW Pharmaceuticals (GWPH) 45,954 89% -870.1 -8% 848 128 205 182 -64 -52 45,400
Vertex Pharmaceuticals (VRTX) 43,431 87% 46.7 29% 7,515 2,261 3,620 3,135 2,144 857 40,027
Regeneron Pharmaceuticals (REGN) 32,266 0% 12.2 15% 13,939 3,435 7,622 0 2,144 2,539 30,869
Alexion Pharmaceuticals (ALXN) 23,581 92% 12.8 10% 14,815 4,448 4,736 4,359 1,470 1,874 23,912
Biomarin Pharmaceutical (BMRN) 12,700 79% 1,194.1 -1% 4,558 1,484 1,250 986 -39 11 13,147
Mylan (MYL) 10,768 34% 12.5 -0% 31,054 19,590 8,309 2,810 -4 1,882 23,458

Balance Sheet ($MM)2018-12-31
Cash569
Accounts Receivable
Inventory
PP&E
Assets58,066
Accounts Payable
Long-Term Debt25,957
Liabilities54,394
Stockholders' Equity
Income Statement ($MM)2018-12-31
Revenue
Cost of Revenue
Gross Profit
R&D
SG&A
Tax
Net Income
Cash Flow ($MM)2018-12-31
Cash Operating
Cash Investing
Cash Financing